dr. Kimberly J. Henderson, MD, JD, assistant medical professor of emergency medicine at the Ichan School of Medicine at Mount Sinai, and Dr. Joshua H. AtkinsMD, PhD, associate professor of anesthesiology and critical care at the hospital of the University of Pennsylvaniato join the SHL Telemedicine US Advisory Board
Tel Aviv, Israel and ZURRICH, July 27, 2022 /PRNewswire/ — SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) (“SHL”), a leading provider and developer of advanced personal telemedicine solutions, today announced the appointment of new key opinion leaders (KOLs) as members of its US. Advisory Board, as part of its strategy to use SmartHeart. to expand significantly® technology in the US.
dr. Kimberly J. Henderson, MD, JD, has more than 17 years of experience in the medical field. dr. Henderson is an assistant medical professor of emergency medicine at the Ichan School of Medicine at Mount Sinai. She is the General Manager and the Associate Medical Director at a multinational investment management and financial services company, where she directly oversees and coordinates the company’s global medical, health and wellness services. Before that, Dr. Henderson was the Senior Medical Director at CVS Health, where she supported enterprise-wide initiatives and retail health programs for 14 years, including oversight of MinuteClinic nurses. dr. Henderson has a JD and MD of George Town University.
dr. Joshua H. Atkins, MD, PhD is an academic anesthesiologist with over 17 years of diverse experience at Penn Medicine, one of the top 3 medical research schools in the US. dr. Atkins is engaged in clinical research that focuses on respiratory monitoring, sleep apnea physiology, and patient safety. He is a consultant to large companies such as Medtronic and Beckton Dickinson (BD) and has extensive experience in advocacy with regulatory and legislative groups.
“We are pleased to have recruited these key opinion leaders to join our US advisory board,” said Erez Nachtomy, CEO of SHL Telemedicine. “We are confident they will play a valuable role in providing insight and guidance to our US team to support our strategy for rapid growth in the US market.”
About SHL Telemedicine
SHL Telemedicine develops and markets personal telemedicine systems and provides medical call center services, with a focus on cardiovascular and related diseases, to end-users and the healthcare industry. SHL Telemedicine provides its services and personal telemedicine devices to subscribers using telephone and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, visit our website at www.shl-telemedicine.com.
Some of the information in this press release contains forward-looking statements. Readers are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results could differ materially from those in the forward-looking statements due to various factors. SHL Telemedicine assumes no obligation to publicly update or revise any forward-looking statements.
Logo – https://mma.prnewswire.com/media/1850421/SHL_Logo.jpg
More information:
Fabienne Farner
IRF
+41 43 244 81 42
farner@irf-reputation.ch
View original content: https://www.prnewswire.com/news-releases/shl-telemedicine-bolsters-its-us-advisory-board-as-the-growth-of-its-smartheart-solution-accelerates-301594094. html
SOURCE SHL Telemedicine Ltd.